They.re back!
Kind regards
Polt E. R. Geist |
They.re back!
Kind regards
Polt E. R. Geist |
petersinthemarket,
Shareprophets have been amazingly prescient with their forecasts on Avacta, including predicting in September 2023 that the placing that Avacta needed would ultimately be done at 50p. Which is the price that the placing was ultimately done at when it was announced on 28 Feb 2024.
JakNife |
I hold no position in AVCT, but I recently came across a Shareprophets article from 2022 whilst searching for something else. I post an extract here. It might be of interest to holders. I have no axe to grind one way or the other, so make of it what you will. pete
''..... my 10 stocks to collapse by Christmas. One has fallen so far it is probably not a short now though I would not buy it while three look set to go to zero, possibly as soon as next week in one case. My 10 are Supply, Chill Brands, Versarien, Avacta (AVCT), Wildcat Petroleum (WCAT), Amigo (AMGO), Cineworld (CINE), Argo Blockchain (ARB), Verditek (VDTK) and Tern (TERN). I also look at the oil price and consider whether those sitting on gains might bank a few profits.'' |
Thanks to Sean Dent on X:
Sean Dent
@SeanDentBsc
First #AVCT treat 6 animals with A6103 (Pre|CISION modified Exetecan), they saw 4 complete responses, 1 with 75% reduction and 1 with approximately 10% reduction
From latest slides it looks like now 8 animals have been treat with 6103, 7 have seen a complete responses and 1 with around 40% reduction.
Every time they present data it gets better and better and better. Remarkable |
Dudishes back ,but as normal missed the rise. Bit like Stormy and The Donald. The Orange clown is about to shaft Ukraine and then make pals with the Chinese haters. |
1.9 losers clubbin in, goodness. |
Oligarchs have financed Trump property empire probably backed by a guarantee from the orange manchild
Just needs a phone call |
Stranger things have happened but i think our CEO will be making good use of her extensive contact lists over the pond ! |
Bbd ...lol. Trump , what a w anchor. The share price has responded well..All will be revealed soon. Reverse takeover by N4P ...lol, lol, lol. TimeLord alert. |
Don’t get me started on Trump except to say that the Ruskies must have something very big on him!! lol
I have a feeling that the new CFO is working on something as we speak. Hell of a risk to be short at this point but then shorting sheep will be sheep especially when they are a little overweight. |
Belgium unit sale probably inked too. |
SP flying on zero news. Wonder if they.ve flogged something else? Either way, a great recovery. Tis what is. Geez, they might have some predator around ...unsure why that would happen BCOS in another 6 months will be trading at 20p ISH. Odd share price action. MMs getting share price artificially high for fwd selling play. Wouldn't surprise me. Bent as ... |
Excellent shorting opportunity. Prepare for a deeply discounted placing. |
Another example today of which market AVCT are now targeting. Smart move imo |
"Following the divestment of Launch Diagnostics, the Company's cash runway will extend into Q1 2026."
Which will be just after they finally complete Phase 1 and publish the data (allegedly). What then another £50 m pay day loan or a placing? |
So have a got this right, Avacta paid £29,201 m to acquire Launch Diagnostics, a Belgium based company and sells it just over 2 years later for £12.91 m back to a Belgium company, a master piece of corporate activity that! |
bbd2,
"Nice. I certainly wouldn’t want to be short"
Why? What do you know about shorting? Have you ever shorted anything ever in your entire life?
Did you read the bit in the RNS that says:
"Following the divestment of Launch Diagnostics, the Company's cash runway will extend into Q1 2026."
What do you think happens in Q1 2026? It's less than a year away!
Did you read anything in either RNS about "Phase 2 trials" and how much they might cost?
No, because there wasn't anything in there about Phase 2! They still haven't finished the Phase 1 trial!
How much cash do you think that they need to run a Phase 2 trial? How about Phase 3?
FFS you're 100% focused on completely the wrong things!
JakNife |
Nice. I certainly wouldn’t want to be short |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
